Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Verhelst

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Soins; La Revue De Reference Infirmiere|July 1, 2018
[Characteristics and epidemiology of chronic kidney disease]David Verhelst
International Journal of Toxicology|September 17, 2004
Acute renal injury following methanol poisoning: analysis of a case seriesDavid Verhelst, Pierre Moulin, Vincent Haufroid, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|December 17, 2003
Defibrination and systemic bleeding caused by an imported African snakebitePhilippe Hantson, David Verhelst, Xavier Wittebole, et al.
Lancet (London, England)|June 3, 2004
Treatment of erythropoietin-induced pure red cell aplasia: a retrospective studyDavid Verhelst, Jérôme Rossert, Nicole Casadevall, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2002
Fanconi syndrome and renal failure induced by tenofovir: a first case reportDavid Verhelst, Matthieu Monge, Jean-Luc Meynard, et al.
Thrombosis Research|August 17, 2002
Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic casesPhilippe Hainaut, Carine Jaumotte, David Verhelst, et al.
Medicine|July 7, 2017
Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective studyNathalie Chavarot, David Verhelst, Agathe Pardon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2016
Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover TrialMohamed Shariful Islam, Zarih Alcheikh Hassan, Florence Chalmin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 6, 2022
Efficacy and safety of methylprednisolone pulse followed by oral prednisone vs. oral prednisone alone in sarcoidosis tubulointerstitial nephritis: a randomized, open-label, controlled clinical trialMatthieu Mahevas, Vincent Audard, Alexandra Rousseau, et al.
Nephrologie & Therapeutique|January 21, 2019
[Clinical management of patients with hemophilia A in nephrology: Diagnostic and therapeutic challenges illustrated by the cases of 2 patients]Mathilde Fedi, Céline Falaise, Antoine Lanot, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Soins; La Revue De Reference Infirmiere|July 1, 2018
[Characteristics and epidemiology of chronic kidney disease]David Verhelst
International Journal of Toxicology|September 17, 2004
Acute renal injury following methanol poisoning: analysis of a case seriesDavid Verhelst, Pierre Moulin, Vincent Haufroid, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|December 17, 2003
Defibrination and systemic bleeding caused by an imported African snakebitePhilippe Hantson, David Verhelst, Xavier Wittebole, et al.
Lancet (London, England)|June 3, 2004
Treatment of erythropoietin-induced pure red cell aplasia: a retrospective studyDavid Verhelst, Jérôme Rossert, Nicole Casadevall, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2002
Fanconi syndrome and renal failure induced by tenofovir: a first case reportDavid Verhelst, Matthieu Monge, Jean-Luc Meynard, et al.
Thrombosis Research|August 17, 2002
Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic casesPhilippe Hainaut, Carine Jaumotte, David Verhelst, et al.
Medicine|July 7, 2017
Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective studyNathalie Chavarot, David Verhelst, Agathe Pardon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2016
Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover TrialMohamed Shariful Islam, Zarih Alcheikh Hassan, Florence Chalmin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 6, 2022
Efficacy and safety of methylprednisolone pulse followed by oral prednisone vs. oral prednisone alone in sarcoidosis tubulointerstitial nephritis: a randomized, open-label, controlled clinical trialMatthieu Mahevas, Vincent Audard, Alexandra Rousseau, et al.
Nephrologie & Therapeutique|January 21, 2019
[Clinical management of patients with hemophilia A in nephrology: Diagnostic and therapeutic challenges illustrated by the cases of 2 patients]Mathilde Fedi, Céline Falaise, Antoine Lanot, et al.
Pageof 2